Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER 134INDUSTRY 62NETWORK 3UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1SCLC,Extensive Stage 1Breast Neoplasms 1

Interventions

Radiotherapy 302Cisplatin 266Cyclophosphamide 230Doxorubicin 177Paclitaxel 170Vincristine 162Carboplatin 152Filgrastim 140Etoposide 139Gemcitabine 118Docetaxel 114Fluorouracil 113Methotrexate 106Dexamethasone 106Cytarabine 106Prednisone 92Leucovorin 90Gene Expression Profiling 82Granulocyte Colony-Stimulating Factor 75Specimen Handling 70Magnetic Resonance Spectroscopy 63Irinotecan 59Capecitabine 59Radiation 54Polymerase Chain Reaction 51Ifosfamide 51Rituximab 49Immunohistochemistry 49Daunorubicin 49Oxaliplatin 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × niraparib × Clear all
NCT05601440 2026-05-07

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

Canadian Cancer Trials Group

Phase 2 Recruiting
484 enrolled
Breast

Breast Neoplasms

NCT05718323 2026-02-06

RAISE

ETOP IBCSG Partners Foundation

Phase 2 Recruiting
44 enrolled
Thoracic

SCLC,Extensive Stage

NCT03088059 2023-11-03

UPSTREAM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Unknown
340 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡